Clinical Trial Evaluating TQB6411 Injection in Participant s With Esophageal Cancer
A phase 1/2 trial of TQB6411 in oesophageal cancer, run by Chia Tai Tianqing Pharmaceutical Group Co., Ltd., now recruiting.
Overview
Clinical Trial Evaluating TQB6411 Injection in Participant s With Esophageal Cancer is a phase 1/2 interventional study registered as NCT07367516 by Chia Tai Tianqing Pharmaceutical Group Co., Ltd., with 105 participants planned, started 2026-02-12 and due to reach its primary completion in 2027-02. Interventions recorded: TQB6411 Injection.
Similar pages
not linked directly; found by shared links- TrialA Clinical Trial on the Efficacy and Safety of TQB6411 for Injection
Shares TQB6411, Sino Biopharmaceutical (Chia Tai Tianqing) and the tag pipeline.
- TrialA Clinical Study on the First-line Treatment of Metastatic Pancreatic Cancer With TQB2916 Injection Combined With Gemcitabine Hydrochloride for Injection and Paclitaxel for Injection (Albumin-bound Type)
Shares Sino Biopharmaceutical (Chia Tai Tianqing) and the tag pipeline.
- TrialClinical Trials of Benmelstobart Injection Combined With Anlotinib Hydrochloride Capsules in the Treatment of Advanced or Unresectable Alveolar Soft Part Sarcoma
Shares Sino Biopharmaceutical (Chia Tai Tianqing) and the tag pipeline.
- TrialThe Clinical Trial of TQB2102 for Injection Against Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer
Shares Sino Biopharmaceutical (Chia Tai Tianqing) and the tag pipeline.
- TrialA Study of Neoadjuvant Treatment With TQB2102 for Injection for Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer
Shares Sino Biopharmaceutical (Chia Tai Tianqing) and the tag pipeline.
- TrialA Study of TQB2102 for Injection in the Treatment of HER2-positive Biliary Tract Cancer
Shares Sino Biopharmaceutical (Chia Tai Tianqing) and the tag pipeline.
- TrialClinical Study Evaluating the Safety, Tolerability, and Preliminary Efficacy of LM-108 ± Penpulimab+Chemotherapy in Advanced Solid Tumors - Cohort C
Shares Sino Biopharmaceutical (Chia Tai Tianqing) and the tag pipeline.
- TrialA Clinical Study to Evaluate the Efficacy and Safety of TQB3702 Tablets Combined With Immunochemotherapy for the Treatment of B-cell Lymphoma
Shares Sino Biopharmaceutical (Chia Tai Tianqing) and the tag pipeline.